A034940 Stock Overview
ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
ChoA Pharmaceutical Co., LTD. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,001.00 |
| 52 Week High | ₩2,015.00 |
| 52 Week Low | ₩797.00 |
| Beta | 0.56 |
| 1 Month Change | 4.27% |
| 3 Month Change | -29.71% |
| 1 Year Change | -49.93% |
| 3 Year Change | -72.95% |
| 5 Year Change | -73.52% |
| Change since IPO | -50.45% |
Recent News & Updates
Some ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940) Shareholders Look For Exit As Shares Take 31% Pounding
Dec 09
ChoA Pharmaceutical (KOSDAQ:034940) Is Carrying A Fair Bit Of Debt
Nov 12Would ChoA Pharmaceutical (KOSDAQ:034940) Be Better Off With Less Debt?
Aug 12Recent updates
Some ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940) Shareholders Look For Exit As Shares Take 31% Pounding
Dec 09ChoA Pharmaceutical (KOSDAQ:034940) Is Carrying A Fair Bit Of Debt
Nov 12Would ChoA Pharmaceutical (KOSDAQ:034940) Be Better Off With Less Debt?
Aug 12ChoA PharmaceuticalLtd (KOSDAQ:034940) Has A Pretty Healthy Balance Sheet
Jan 31
Did You Miss ChoA PharmaceuticalLtd's (KOSDAQ:034940) 36% Share Price Gain?
Dec 09Shareholder Returns
| A034940 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 9.2% | -1.7% | -3.7% |
| 1Y | -49.9% | 0.1% | -10.4% |
Return vs Industry: A034940 underperformed the KR Pharmaceuticals industry which returned 0.1% over the past year.
Return vs Market: A034940 underperformed the KR Market which returned -10.4% over the past year.
Price Volatility
| A034940 volatility | |
|---|---|
| A034940 Average Weekly Movement | 7.6% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.7% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A034940 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A034940's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1964 | 254 | Sung-Hwan Cho | www.choa.co.kr |
ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral nervous system; gynecologic diseases; antibiotics, antigens, and anthelmintic; and antitumor, as well as other metabolite medicines. The company offers its products in the form of tablets, capsules, granules, syrups, solutions, drinkable ampoules, and sachets.
ChoA Pharmaceutical Co., LTD. Fundamentals Summary
| A034940 fundamental statistics | |
|---|---|
| Market cap | ₩31.38b |
| Earnings (TTM) | -₩13.07b |
| Revenue (TTM) | ₩61.46b |
0.5x
P/S Ratio-2.4x
P/E RatioIs A034940 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A034940 income statement (TTM) | |
|---|---|
| Revenue | ₩61.46b |
| Cost of Revenue | ₩40.36b |
| Gross Profit | ₩21.10b |
| Other Expenses | ₩34.17b |
| Earnings | -₩13.07b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -421.95 |
| Gross Margin | 34.33% |
| Net Profit Margin | -21.27% |
| Debt/Equity Ratio | 69.8% |
How did A034940 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 12:42 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ChoA Pharmaceutical Co., LTD. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|